Ingredients | Amount Per Serving |
---|---|
(S-4)
|
50 mg |
Creatine
Below is general information about the effectiveness of the known ingredients contained in the product S-4 Andarine. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
There is insufficient reliable information available about the effectiveness of andarine.
Below is general information about the safety of the known ingredients contained in the product S-4 Andarine. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
POSSIBLY UNSAFE ...when used orally. There are concerns about the potential of andarine and other selective androgen receptor modulators (SARMs) to cause serious adverse reactions, including hepatotoxicity, myocardial infarction, and stroke (98840). No long-term safety studies have been conducted (98840).
PREGNANCY AND LACTATION:
Insufficient reliable information available; avoid using.
Below is general information about the interactions of the known ingredients contained in the product S-4 Andarine. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
Below is general information about the adverse effects of the known ingredients contained in the product S-4 Andarine. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
General ...Orally, selective androgen receptor modulators, such as andarine, could potentially increase the risk of myocardial infarction, stroke, and liver toxicity (98840). However, no thorough safety evaluations of andarine have been conducted.
Cardiovascular ...The FDA has warned that selective androgen receptor modulators, such as andarine, could potentially increase the risk of myocardial infarction and stroke (98840).
Hepatic ...The FDA has warned that selective androgen receptor modulators, such as andarine, could potentially increase the risk of liver toxicity (98840).